Director Collins Implores Congress To Set Predictable NIH Funding Growth
This article was originally published in The Gray Sheet
Executive Summary
The best way to accelerate medical cures, National Institutes of Health Director Francis Collins tells a congressional 21st Century Cures coalition, is to make sure that NIH researchers are supplied with a steady, predictable source of grant funding.
You may also be interested in...
Shuren Highlights CDRH Actions To Ease Trial Burdens On Capitol Hill
CDRH Director Jeffrey Shuren participated in the first roundtable of a newly launched House Energy and Commerce Committee initiative to accelerate drug and device development. He emphasized the device center’s recent proposals to minimize pre-market data collection with postmarket controls, and supported the promise of clinical trial networks.
3-D Printing Enables Research On Bioprinted Human Organs
Organovo has delivered its first 3-D printed liver tissue to an outside lab for further analysis, highlighting the advent of synthetically produced human organs. Scientists who received a government grant to do research in that arena told “The Gray Sheet” that bioprinting living human cells made it all possible.
Shutdown Realities At FDA: No New Submission Reviews, And More
New PMA and 510(k) submissions, and anything else tied to an FY 2014 user fee payment, are not being reviewed by FDA as of Oct. 1. The limited carryover-FY 2013 user fees FDA has are supporting ongoing reviews, while the registration and listing and export certification database entry systems are unavailable.